|
CWC27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.631590E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.306800E-01 |
| Normal-vs-Stage2 |
2.764400E-01 |
| Normal-vs-Stage3 |
6.45799999999808E-05 |
| Normal-vs-Stage4 |
6.222600E-03 |
| Stage1-vs-Stage2 |
4.034800E-01 |
| Stage1-vs-Stage3 |
1.181670E-04 |
| Stage1-vs-Stage4 |
1.447740E-02 |
| Stage2-vs-Stage3 |
7.592400E-02 |
| Stage2-vs-Stage4 |
3.188600E-01 |
| Stage3-vs-Stage4 |
4.026200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.815600E-02 |
| Normal-vs-AfricanAmerican |
1.179740E-02 |
| Normal-vs-Asian |
4.982100E-02 |
| Caucasian-vs-AfricanAmerican |
1.874150E-01 |
| Caucasian-vs-Asian |
3.596600E-01 |
| AfricanAmerican-vs-Asian |
6.900000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.231500E-02 |
| Normal-vs-Female |
4.408100E-02 |
| Male-vs-Female |
9.494800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.541400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.314210E-02 |
| Normal-vs-Age(61-80Yrs) |
1.722360E-01 |
| Normal-vs-Age(81-100Yrs) |
5.084300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.258800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.520560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.592800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.258400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.283600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.633610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.101210E-01 |
| Normal-vs-Grade 2 |
7.250400E-01 |
| Normal-vs-Grade 3 |
1.480750E-03 |
| Normal-vs-Grade 4 |
1.419190E-04 |
| Grade 1-vs-Grade 2 |
1.871450E-01 |
| Grade 1-vs-Grade 3 |
1.621760E-02 |
| Grade 1-vs-Grade 4 |
1.796980E-03 |
| Grade 2-vs-Grade 3 |
1.600600E-03 |
| Grade 2-vs-Grade 4 |
2.583000E-04 |
| Grade 3-vs-Grade 4 |
1.894360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.342400E-01 |
| Normal-vs-ccB subtype |
9.88029999999807E-05 |
| ccA subtype-vs-ccB subtype |
6.61189999973111E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.700100E-02 |
| Normal-vs-N1 |
2.599600E-03 |
| N0-vs-N1 |
1.374990E-01 |
|
|
